Exercise-Induced Alternations of Adiponectin, Interleukin-8 and Indicators of Carbohydrate Metabolism in Males with Metabolic Syndrome.


Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
18 05 2023
Historique:
received: 14 04 2023
revised: 12 05 2023
accepted: 16 05 2023
medline: 29 5 2023
pubmed: 27 5 2023
entrez: 27 5 2023
Statut: epublish

Résumé

Adiponectin (ADIPO) and interleukin-8 (IL-8) are proteins that play a significant, albeit opposing, role in metabolic syndrome (MetS). The reported data on the effect of physical activity on the levels of these hormones in the population of people with MetS are conflicting. The aim of the study was to evaluate the changes in hormone concentrations, insulin-resistance indices and body composition after two types of training. The study included 62 men with MetS (age 36.6 ± 6.9 years, body fat [BF] = 37.53 ± 4.5%), randomly assigned to: an experimental group EG1 (n = 21) with aerobic exercise intervention, an experimental group EG2 (n = 21) with combined aerobic and resistance exercise intervention, both for 12 weeks, and a control group CG (n = 20) without interventions. Anthropometric measurements and body composition (fat-free mass [FFM], gynoid body fat [GYNOID]), as well as a biochemical blood analysis (adiponectin [ADIPO], interleukin-8 [IL-8], homeostatic model assessment-adiponectin (HOMA-AD) and homeostatic model assessment-triglycerides (HOMA-TG) were performed at baseline, and at 6 and 12 weeks of intervention and 4 weeks after the intervention (follow-up). Intergroup (between groups) and intragroup (within each group) changes were statistically evaluated. In the experimental groups EG1 and EG2, no significant changes were observed in the ADIPO concentration, but a decrease of GYNOID and insulin-resistance indices was confirmed. The aerobic training led to favorable changes in IL-8 concentration. The use of combined resistance and aerobic training led to improved body composition, decreased waist circumference and better insulin-resistance indices in men with MetS.

Identifiants

pubmed: 37238721
pii: biom13050852
doi: 10.3390/biom13050852
pmc: PMC10216579
pii:
doi:

Substances chimiques

Adiponectin 0
Interleukin-8 0
Insulin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Curr Rheumatol Rep. 2017 Aug 26;19(10):60
pubmed: 28844079
J Clin Med. 2019 May 18;8(5):
pubmed: 31109070
Am J Physiol Endocrinol Metab. 2004 Jan;286(1):E8-13
pubmed: 13129857
Med Sci Sports Exerc. 2011 Jul;43(7):1334-59
pubmed: 21694556
Adipocyte. 2018 Jan 2;7(1):57-62
pubmed: 29205099
Diabetes. 1996 Jan;45(1):28-36
pubmed: 8522056
Tidsskr Nor Laegeforen. 2018 May 08;138(8):
pubmed: 29737766
Sports Med Open. 2020 Jul 17;6(1):31
pubmed: 32681399
J Lipid Res. 2007 Jun;48(6):1253-62
pubmed: 17374880
Med Sci Sports Exerc. 2011 Aug;43(8):1575-81
pubmed: 21681120
Diabetol Metab Syndr. 2019 Jun 14;11:44
pubmed: 31223343
Am J Physiol Endocrinol Metab. 2015 Jul 1;309(1):E22-34
pubmed: 25944879
Clin Nutr. 2020 Oct;39(10):3092-3098
pubmed: 32063406
J Clin Endocrinol Metab. 2015 Mar;100(3):870-9
pubmed: 25514103
Circulation. 2002 Jun 18;105(24):2893-8
pubmed: 12070119
J Clin Med. 2023 Apr 12;12(8):
pubmed: 37109160
Compr Physiol. 2018 Jun 18;8(3):1031-1063
pubmed: 29978896
Ann Nutr Metab. 2016;68(3):173-9
pubmed: 26895247
PLoS One. 2018 Aug 16;13(8):e0201585
pubmed: 30114249
FASEB J. 2001 Apr;15(6):958-69
pubmed: 11292656
Biol Res Nurs. 2021 Apr;23(2):280-292
pubmed: 32938197
Int J Mol Sci. 2022 Jun 24;23(13):
pubmed: 35806052
Exp Physiol. 2007 Jan;92(1):233-40
pubmed: 17030560
Endocrine. 2014 Jun;46(2):231-40
pubmed: 24287790
Nature. 2003 Jun 12;423(6941):762-9
pubmed: 12802337
Eur J Clin Invest. 2008 Oct;38(10):743-51
pubmed: 18837799
Chron Respir Dis. 2017 Nov;14(4):342-351
pubmed: 27075360
Metabolism. 2015 Jan;64(1):131-45
pubmed: 25497344
Horm Metab Res. 2017 Mar;49(3):164-173
pubmed: 28249299
Int Immunopharmacol. 2018 Mar;56:217-221
pubmed: 29414654
J Inflamm (Lond). 2018 May 09;15:9
pubmed: 29760587
EBioMedicine. 2019 Nov;49:381-388
pubmed: 31662290
Diabetes Res Clin Pract. 2007 Jul;77(1):151-4
pubmed: 17081646
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
pubmed: 12900694
Int J Mol Sci. 2017 Jun 21;18(6):
pubmed: 28635626
Growth Factors. 2019 Dec;37(5-6):238-246
pubmed: 32160769
Metabolism. 2014 Mar;63(3):431-40
pubmed: 24355625
J Obes. 2013;2013:409679
pubmed: 23533722
Am J Hum Biol. 2008 Jan-Feb;20(1):100-9
pubmed: 17963225
J Clin Invest. 2000 Jul;106(2):171-6
pubmed: 10903330
J Sci Med Sport. 2009 Mar;12(2):310-6
pubmed: 18078784
Horm Metab Res. 2000 Nov-Dec;32(11-12):537-41
pubmed: 11246821
Int J Obes (Lond). 2009 Apr;33(4):456-64
pubmed: 19238154
Nutrition. 2016 Mar;32(3):338-48
pubmed: 26706026
Sports Med. 2001 Feb;31(2):115-44
pubmed: 11227979
Nutr Metab Cardiovasc Dis. 2010 Oct;20(8):608-17
pubmed: 19695853
Nutr Rev. 2011 Mar;69(3):145-54
pubmed: 21348878
J Biol Chem. 1997 Nov 21;272(47):29911-8
pubmed: 9368067
J Clin Endocrinol Metab. 2001 Mar;86(3):1267-73
pubmed: 11238519
Diabetologia. 2000 Jul;43(7):821-35
pubmed: 10952453
Med Sci Sports Exerc. 2001 Jun;33(6 Suppl):S379-99; discussion S419-20
pubmed: 11427763
Exp Gerontol. 2019 Nov;127:110715
pubmed: 31473199
J Biosoc Sci. 2009 Jan;41(1):139-54
pubmed: 18442432
PLoS One. 2014 Sep 02;9(9):e105056
pubmed: 25180496
JAMA. 2003 Apr 9;289(14):1799-804
pubmed: 12684358
J Exp Psychol Gen. 2012 Feb;141(1):2-18
pubmed: 21823805
Healthcare (Basel). 2022 Aug 25;10(9):
pubmed: 36141228
J Am Coll Cardiol. 2001 Jan;37(1):153-6
pubmed: 11153730
J Physiol Pharmacol. 2015 Jun;66(3):463-70
pubmed: 26084228
J Clin Med. 2023 Jan 03;12(1):
pubmed: 36615169
Nat Med. 2001 Aug;7(8):941-6
pubmed: 11479627
JAMA. 1993 Dec 15;270(23):2823-8
pubmed: 8133621
Diabet Med. 2006 May;23(5):469-80
pubmed: 16681555
Hippokratia. 2008 Apr;12(2):81-6
pubmed: 18923660
Diabetologia. 2003 Apr;46(4):459-69
pubmed: 12687327
Int J Sports Med. 1997 Oct;18 Suppl 4:S314-7
pubmed: 9391847
Med Sci (Basel). 2018 Oct 30;6(4):
pubmed: 30380802
Mediators Inflamm. 2010;2010:513948
pubmed: 20508843
PLoS One. 2012;7(4):e34916
pubmed: 22514690
Int J Obes (Lond). 2009 Mar;33(3):296-304
pubmed: 19153580
Am J Clin Nutr. 2008 Jul;88(1):125-32
pubmed: 18614732
J Clin Invest. 2004 Dec;114(12):1752-61
pubmed: 15599400
Exp Gerontol. 2020 Oct 1;139:111022
pubmed: 32707318

Auteurs

Karol Makiel (K)

Department of Anatomy, Faculty of Physical Rehabilitation, University of Physical Education, 31-571 Cracow, Poland.

Agnieszka Suder (A)

Department of Anatomy, Faculty of Physical Rehabilitation, University of Physical Education, 31-571 Cracow, Poland.

Aneta Targosz (A)

Department of Physiology, Faculty of Medicine, Jagiellonian University Medical College, 31-531 Cracow, Poland.

Marcin Maciejczyk (M)

Department of Physiology and Biochemistry, Faculty of Physical Education and Sport, University of Physical Education, 31-571 Cracow, Poland.

Alon Haim (A)

Department of Pediatric Endocrinology and Diabetes, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 653, Israel.
Soroka University Medical Center, Beer-Sheva 151, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH